Literature DB >> 19879063

Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity.

Randi J Reidunsdatter1, Jo-Asmund Lund, Per Fransson, Anders Widmark, Sophie D Fosså, Stein Kaasa.   

Abstract

PURPOSE: Several treatment options are available for patients with prostate cancer. Applicable and valid self-assessment instruments for assessing health-related quality of life (HRQOL) are of paramount importance. The aim of this study was to explore the validity and responsiveness of the intestinal part of the prostate cancer-specific questionnaire QUFW94. METHODS AND MATERIALS: The content of the intestinal part of QUFW94 was examined by evaluation of experienced clinicians and reviewing the literature. The psychometric properties and responsiveness were assessed by analyzing HRQOL data from the randomized study Scandinavian Prostate Cancer Group 7 (SPCG)/Swedish Association for Urological Oncology 3 (SFUO). Subscales were constructed by means of exploratory factor analyses. Internal consistency was assessed by Cronbach's alpha. Responsiveness was investigated by comparing baseline scores with the 4-year posttreatment follow-up.
RESULTS: The content validity was found acceptable, but some amendments were proposed. The factor analyses revealed two symptom scales. The first scale comprised five items regarding general stool problems, frequency, incontinence, need to plan toilet visits, and daily activity. Cronbach's alpha at 0.83 indicated acceptable homogeneity. The second scale was less consistent with a Cronbach's alpha at 0.55. The overall responsiveness was found to be very satisfactory.
CONCLUSION: Two scales were identified in the bowel dimension of the QUFW94; the first one had good internal consistency. The responsiveness was excellent, and some modifications are suggested to strengthen the content validity. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879063     DOI: 10.1016/j.ijrobp.2009.05.057

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial.

Authors:  Anne-Lise Poirier; Fabrice Kwiatkowski; Jean-Marie Commer; Bénédicte D'Aillières; Virginie Berger; Mariette Mercier; Franck Bonnetain
Journal:  Trials       Date:  2012-04-20       Impact factor: 2.279

2.  Population-based study of long-term functional outcomes after prostate cancer treatment.

Authors:  Sigrid Carlsson; Linda Drevin; Stacy Loeb; Anders Widmark; Ingela Franck Lissbrant; David Robinson; Eva Johansson; Pär Stattin; Per Fransson
Journal:  BJU Int       Date:  2015-06-23       Impact factor: 5.588

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.